Beiersdorf stock slips 0.21% to EUR 85.50 premarket
Published on 11/05/2026 at 08:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points for investors
- NIVEA weakness remains a central issue for Beiersdorf as investors assess the brand's turnaround.
- Derma and La Prairie provide operating offsets within the consumer business.
- Management's unchanged 2026 outlook remains an important reference for the next trading sessions.
Beiersdorf stock traded at EUR 85.50 on Lang & Schwarz at 08:27 CET on Thursday, November 5, 2026, 0.21 percent below the Xetra close of Wednesday, November 4, at EUR 85.68.
The premarket move places the focus on the balance between weaker NIVEA momentum and stronger contributions from Derma and La Prairie. The company kept its 2026 outlook unchanged, leaving the development of its core brands and the execution of the turnaround as key issues for investors.
NIVEA weakness sets the tone
Beiersdorf's consumer business remains closely watched as investors weigh the pressure on NIVEA against growth in other care and premium brands. The mix will matter for the company's sales trajectory and for confidence in its unchanged full-year outlook.
The real-time quote of Beiersdorf stock provides the latest trading reference.
The DAX provides the broader market backdrop for the German-listed company.
Further attention is likely to remain on brand momentum, the progress of the NIVEA turnaround and any update to the 2026 outlook. More news and analyses on Beiersdorf stock cover the latest developments.
